key: cord-0730978-v47tyon2
authors: McCarthy, Colin J.; Sheth, Rahul A.; Patel, Rakhi J.; Cheung, Sheree H.; Simon, Nicole Z.; Huang, Steven Y.; Gupta, Sanjay
title: Deployment of an Interventional Radiology telemedicine program during the COVID-19 pandemic: initial experience with 10,056 visits.
date: 2021-12-08
journal: J Am Coll Radiol
DOI: 10.1016/j.jacr.2021.10.022
sha: ce844216c6bc92533a8cdd37840b54ad310f2174
doc_id: 730978
cord_uid: v47tyon2

OBJECTIVE: To evaluate the clinical, operational, and financial effects of using telemedicine services in an academic interventional radiology setting during the coronavirus disease 2019 pandemic and to identify potential barriers to equitable telemedicine access for patients. METHODS: Evaluation and management (E&M) data over a 104-week period from September 2019 to August 2021 were reviewed. Data related to the visits were recorded including visit type, billing provider, patient demographic information, Current Procedural Terminology code charged, and reimbursement received. The ZIP code pertaining to the patient's primary residence was matched with median household income from the US Census Bureau. RESULTS: In all, 14,754 E&M encounters were performed over the study period, of which 10,056 were conducted using telemedicine. Twenty-two percent of visits were performed with interactive video; the remainder were performed using audio only. Female patients were more likely than male patients to use interactive video visits for telemedicine encounters (23.7% versus 20.4%, P < .001). Patients availing of video visits (mean age, 58.1 years, SD = 14.0) were also significantly younger than those patients who used audio-only (telephone) encounters (mean age, 62.5 years, SD = 13.3). Patients with private insurance and those living in neighborhoods with higher median household income were more likely to avail of interactive video visits (P < .001). Professional E&M monthly revenue was between 23.3% and 53.2% of peak prepandemic levels (mean 37.7%). CONCLUSION: Telemedicine services allowed for rapid restoration of E&M encounter volumes over the study period. Further work is required to determine the potential implementation barriers to increasing the use of video visits.

The initial case of COVID-19 in the United States was detected in late January 2020 [1] , and within approximately two months, the increasing impact of the disease on the general population required considerable changes to the delivery of healthcare. For those patients with a diagnosis of cancer, for example, this presented several challenges, including access to diagnostics [2] [3] [4] , chemotherapy [5] , radiation therapy, surgery [5, 6] , clinical trials [7] , interventional oncology [8] and other tenets of oncologic care. Cancer patients have been shown to be at significantly increased risk for COVID-19 infection, and its adverse outcomes after adjusting for COVID-19 risk factors [9] . Patients with cancer are also more likely to suffer infections in general due to immunosuppression. Interventional radiology is similar to other procedure-based specialties, where clinic visits are necessary to discuss the risks, benefits and alternatives of image-guided therapy, and to address post-procedure care.

Prior to the onset of the pandemic, our group saw approximately 6,500 -7,500 patients in clinic annually, with no formal telemedicine program. A limited number of non-billable telephone encounters were performed each month. At the beginning of the pandemic, a concerted effort was made by our institution to decrease the number of patients physically on our campuses where possible. Therefore, efforts were made to develop a robust IR telemedicine program.

Herein, the immediate impact to the provision of IR Clinic services at an academic medical center is reviewed, including the clinical, operational and financial impacts of using telemedicine services, together with potential implementation barriers to ensuring equitable patient access.

This study does not qualify as human subject research and does not meet the requirement for institutional review board submission, as only retrospective administrative and billing data were reviewed in aggregate, containing no individually identifying items. We retrospectively reviewed For those patients who needed contact with the IR clinic, either for follow-up or as part of a preprocedure evaluation, this was initially performed exclusively by telephone. Once the applicable licensing and regulatory requirements for telemedicine billing were established, it was possible to submit charges for these visits, when appropriate. The number of telephone encounters increased rapidly over the course of several weeks. Prior to the pandemic, telephone encounters represented the minority of monthly encounters, representing on average just 2.4% of all monthly clinic visits (range 0.4 -3.7%). In total, 127 non-billed telephone visits were completed during the pre-pandemic period.

With the availability of both telephone and video visits starting in June 2020, total clinic encounters in June (n = 595), July (n = 625) and August 2020 (n = 537) were at 94.6%, 99.4% and 85.4% of average monthly pre-pandemic volume (n = 629), respectively. Patients were contacted by members of our operations team to determine their preference for video or telephone visit, and to confirm suitability based on their physical location at the time of the J o u r n a l P r e -p r o o f planned telemedicine visit. Technical assistance was offered by members of the IR team when required, and in cases that could not be resolved, patients were directed to an Institutional help desk. The volume of clinic encounters remained relatively stable over the coming months ( Figure   2 ), however the overwhelming majority (77.2%) of such encounters continue to be performed with audio-only. Following the phased re-introduction of in-person visits beginning April 2021, the monthly IR clinic volume for the final 6 months of the study (March 2021 -August 2021) was 763.3 visits (range 644 -832), representing a 21.5% increase over pre-pandemic visits.

Professional E&M revenue (including APPs and MDs) from June 2020 -May 2021 was below peak pre-pandemic levels (mean 37.7%, range 23.3% -53.2%, Figure 3 ). Physician-billed E&M monthly visits averaged 38.0 (range 23 -52) in the period from September 2019 -March 2020.

However, in the fourteen month period from April 2020 -May 2021, inclusive, there was a 57% reduction in similar visits, with an average of 16.3 physician-billed visits per month (range 5 -30), a finding that was statistically significant (p <0.001). In the period prior to the deployment of the telemedicine program (September 2019 -March 2020), 86.4% of all clinic encounters had associated charges that were submitted for reimbursement. However, in the following 13 months for which revenue information is available, the number of encounters associated with charges decreased to 69.2%.

When it came to access to telemedicine, females were more likely than males to utilize interactive video visits for telemedicine encounters (23.7% vs 20.4%, p < .001). Patients availing of video visits (mean age, 58.1 years, SD = 14.0) were also significantly younger than those patients who use audio only (telephone) encounters (mean age 62.5 years, SD = 13.3). Ethnicity was not a significant predictor for the use of interactive video over audio-only visits (p = 0.11).

Patients with private insurance (Table 1) were significantly more likely to use interactive video J o u r n a l P r e -p r o o f visits over those without private insurance (p < .001). Finally, patients living in areas with higher median household income ( Figure 4) were also more likely to use video visits (p < .001).

With the return of in-person visits in the final three months of the study (June -August 2021), monthly E&M visits completed in-person ranged from 14.8% -16.5% of all visits (average 15.9%).

J o u r n a l P r e -p r o o f Discussion Deployment of a comprehensive telemedicine program allowed for rapid restoration of IR Clinic volumes. Those who were more likely to complete their visit using interactive video were younger patients, females, those with private insurance and patients with a primary ZIP-code associated with higher median household income based on US Census data. Despite availability of interactive video visits, the majority of telemedicine encounters were performed using audio only.

Due to State-specific heterogeneity in the requirements to provide telemedicine services to patients, a web-based tool was developed and updated by the institution to guide providers on the types of permitted visits. Written instructions on best practices for video and phone appointments, including environment setup, background noise and establishing rapport were made available to providers. In addition, temporary telemedicine licenses were requested for both IR physicians and advanced practice providers in some neighboring States. Some States do not permit telemedicine services with an out-of-state provider, although telephone calls (nonbillable) or portal-based conversations with an existing patient regarding a prior in-person encounter are generally appropriate across all states.

We identified a negative impact on E&M reimbursement during pandemic conditions, despite availability of telemedicine visits. This was related to a 17% increase in non-billed encounters, and the predominance of telephone encounters over video visits. New and Established outpatient video visits allow for use of "conventional" E&M CPT codes, with providers billing based on medical decision making or all time spent on the encounter that day. However, audio-only or telephone encounters require use of different codes (99441 -99443), for which billing is based only on the amount of time spent in medical discussion with the patient. There was also a J o u r n a l P r e -p r o o f decrease in the number of physician-billed clinic encounters with the availability of telemedicine, which may be related to challenges incorporating such visits into physician daily workflow. All visits were completed using the existing complement of IR physicians and APPs.

The initial setup costs, including platform updates to the electronic medical record system, hardware purchases (including web cameras, for example), and applications for Out-of-State telemedicine licenses when necessary, were funded by the institution.

Prior to the pandemic, "virtual visits" and other telemedicine encounters represented the minority of healthcare interactions [12] . Although patients have increasingly had access to their providers in the form of electronic mail and secure messaging platforms, the widespread availability of interactive video consultation has been hampered by various factors. These include privacy concerns [13] , required spending on information technology infrastructure [14] , medicolegal issues [12, 13, 15] , regulatory restrictions and actual or perceived potential for negative financial impacts[16].

Our study demonstrates that even with the availability of video visits, telephone encounters remained an important component of maintaining IR clinic access, a finding that others have also described [17] . Providers should be familiar with the CPT codes and associated reimbursement for telemedicine encounters. As pandemic conditions evolve, a return to in-person clinic visits may preferable based on patient experience, operational workflow and provider preference, and staffing models may need to be adjusted to reflect this change. Some groups may elect to offer video-visits or in-person visits, for example, with the intention of decreasing the use of audioonly encounters. With the return of in-person visits at our Instituion, approximately 16% of E&M encounters are now completed in-person. Selection of in-person visits depends on patient preference, provider availability, and compliance with social distancing guidelines in the waiting J o u r n a l P r e -p r o o f areas, for example. It is expected that this number will increase over time, but that telemedicine will remain part of our practice in the future.

Although telemedicine was initially envisioned as a way of providing access to medical care for remote communities [13] , use of the technology during the pandemic has demonstrated the potential benefits to many patients, regardless of geographic location or medical condition. The Centers for Medicare & Medicaid Services (CMS) increased access to telehealth services during the COVID-19 Public Health Emergency [18] , adding 85 telehealth services that are reimbursed at the same rate as in-person visits [19] . Coverage amongst private insurers varies amongst various factors, include State. However, it remains to be seen whether this option will remain available beyond the pandemic, and there may be financial disincentives for providers and healthcare organizations to continue widespread adoption of telemedicine when pandemic conditions abate.

Nonetheless, availability of telemedicine had slowly been increasing in the years leading up to the pandemic. In one study where patients were asked why they would choose a telemedicine visit over a clinic visit, the factors outlined included avoiding the risk of COVID transmission, less waiting time, and the potential to save money on travel [20] . In the same study, the majority (80.8%) of surveyed providers desired the option to use telemedicine in the future.

The roll-out of telemedicine services since the start of the pandemic has been well described.

One large academic medical center in New York reported an increase in virtual urgent care visits from 82 to 1,336 in 15 days [21] , with the addition of approximately 250 "surge providers" from other medical specialties to assist existing emergency medicine providers. For non-urgent visits, video encounters increased from less than 50 per day to more than 7,000 per day, within a 10day period.

The impetus to provide ongoing synchronous and asynchronous telemedicine access may be limited by changes in reimbursement models after the public health emergency. However, any decrease in reimbursement may be offset by other advantages, including patient satisfaction, operational efficiencies and decreased provider burnout [20] . In the United States, there is considerable heterogeneity between States when it comes to coverage for telemedicine services.

In 2019, 42 States and the District of Columbia had laws that addressed telemedicine coverage by commercial payers. Of these, 16 states had laws that specifically addressed the reimbursement of telehealth services, 10 of which provided for "payment parity" when compared to in-person visits [22] . Although few States had telehealth parity laws prior to the pandemic [19] , several have now passed temporary telehealth parity laws [23] .

Some groups have advocated for the concept of payment equity, rather than payment parity [23] .

Although payment parity may have been introduced as a stop-gap measure, that model may not be sustainable in the long term, as telemedicine visits tend to be shorter than in-person visits.

Widespread use of telemedicine by providers may allow for more patient encounters per unit time, raising the possibility that such visits such be reimbursed at close to, but less than, inperson visits. In the future, it may be useful for individual practices to evaluate their overall efficiency with E&M encounters, in terms of staffing models, resource utilization and inpatient versus ambulatory visits.

Maintaining or increasing access to telemedicine for IR patients in the post-pandemic period offers the possibility of allowing patients to discuss treatments without traveling to the hospital or clinic, including potentially inviting family members in remote locations to join the virtual consult. For post-procedure patients, telemedicine may allow for the remote evaluation of wounds (following implanted port placement, for example) [24] . Access to such services may J o u r n a l P r e -p r o o f reduce the frequency of hospital visits. This is particularly important to cancer patients, who have higher risk of developing severe effects related to COVID-19 [25] .

Shah et al. recently reported that telemedicine reduced time from initial referral to biopsy from 17 to 12 days for Interventional Radiology patients [26] . For the 172 telemedicine visits in that cohort, the authors reported that telemedicine saved patients a total of 367 hours of travel time and 11,222 miles in travel distance. There are also potential economic benefits to patients, related to less time away from work and travel expenses associated with attending appointments.

Conversely, there are some who believe telemedicine should be a temporary solution for the duration of the public health emergency, citing issue surround quality and fragmentation of medical care [27] . However, based on provider and patient experiences to date, it is clear that telemedicine will almost certainly play an increasing role in healthcare delivery during the pandemic and beyond. Many long-term challenges remain in the form of regulations, licensing and reimbursement. Some have proposed federal licensing for telemedicine services [23] , as a potential method of addressing geographical hurdles. Others have suggested that reciprocity of medical licenses between States may provide a viable option, similar to the rules applying to physicians practicing in the VA system [28] . Finally, the Interstate Medical Licensure Compact may streamline physician licensing across state lines [29] , facilitating the ongoing provision of telemedicine services beyond the COVID-19 pandemic.

There are limitations to this study. Ad-hoc patient-initiated or provider-initiated telephone encounters may not have been counted, if they were not associated with the creation of a "telephone encounter" within the electronic medical record. Some brief telephone interactions may not be captured on either financial or clinical operational datasets. The study was J o u r n a l P r e -p r o o f retrospective in nature and involved visits at a single institution. The results may not be generally applicable to other practices, particularly given the focus on cancer treatment at our facility.

Our findings demonstrate the telemedicine services can be delivered effectively for Interventional Radiology patients, but challenges remain with the widespread implementation of synchronous video visits. Further work is required to determine the potential implementation barriers to increasing the proportion of telemedicine encounters using video technology, and to monitor changes in Federal and State requirements for the provision of telemedicine services. Characteristics of patients accessing in-person and telemedicine services over the study period.

J o u r n a l P r e -p r o o f [REDACTED for blinding purposes]

Relative distribution of all telemedicine encounters based on patient's home ZIP code (April 2020 -August 2021). A total of 9 visits were performed for residents of US Overseas territories (not shown). Graph outlining distribution of telephone encounters, in-person consultations and video consultations over the study period. 

First Case of 2019 Novel Coronavirus in the United States

The Economic Impact of the COVID-19 Pandemic on Radiology Practices

COVID-19: Safe Guidelines for Breast Imaging During the Pandemic

ACR Statement on Safe Resumption of Routine Radiology Care During the Coronavirus Disease 2019 (COVID-19) Pandemic

A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group

Guidance for management of cancer surgery during the COVID-19 pandemic

Rethinking cancer clinical trials for COVID-19 and beyond

Interventional oncology at the time of COVID-19 pandemic: Problems and solutions

Notification of enforcement discretion for telehealth remote communications during the COVID-19 nationwide public health emergency

In-Person Health Care as Option B

Telemedicine: medical, legal and ethical perspectives

The Current Pediatric Telehealth Landscape

Cost-utility and cost-effectiveness studies of telemedicine, electronic, and mobile health systems in the literature: a systematic review

The Role of Telemedicine in the Maintenance of IR Outpatient Evaluation and Management Volume During the COVID-19 Global Pandemic

Medicare Telemedicine Health Care Provider Fact Sheet

The Importance of Temporary Telehealth Parity Laws to Improve Public Health During COVID-19 and Future Pandemics

Implications for Telemedicine for Surgery Patients After COVID-19: Survey of Patient and Provider Experiences

COVID-19 transforms health care through telemedicine: Evidence from the field

50-State Survey of Telehealth Commercial Payer Statutes

Implications for Telehealth in a Postpandemic Future: Regulatory and Privacy Issues

Feasibility and safety of surgical wound remote follow-up by smart phone in appendectomy: A pilot study

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

Telemedicine visits reduce time to biopsy, travel time and costs for interventional radiology patients

Direct-to-Consumer Telemedicine

Telemedicine and Medical Licensure -Potential Paths for Reform

The Interstate Medical Licensure Compact: Attending to the Underserved

The authors wish to acknowledge the assistance of Carol L. Pieranunzi, Prin EHR Sys Analyst, EHR Analytics & Reporting, for her help with data collection.

[REDACTED]